Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 4Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Myeloid, Acute 4Lymphoma 3Neoplasm, Residual 2Lymphoma, Non-Hodgkin 2Breast Neoplasms 2Retinoblastoma 1Recurrence 1Prostatic Neoplasms 1Neuroblastoma 1Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Mediastinal Neoplasms 1Lymphoma, Large-Cell, Anaplastic 1Leukemia 1Hepatoblastoma 1Chemotherapy-Induced Febrile Neutropenia 1Burkitt Lymphoma 1

Interventions

Dexamethasone 8Oxycodone 6Epoetin Alfa 5Propofol 4Palonosetron 4Meropenem 4Zoledronic Acid 3Vancomycin 3Sevoflurane 3Ondansetron 3Naloxone 3Everolimus 3Ciprofloxacin 3Cholecalciferol 3Ceftazidime 3Cefepime 3Calcium Dobesilate 3Bevacizumab 3Aspirin 3Aprepitant 3peginterferon alfa-2a 2edoxaban 2apixaban 2apatinib 2Vitamin B 12 2Vincristine 2Tobacco Use Cessation Devices 2Teicoplanin 2Tablets 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Neoplasms × Granulocyte Colony-Stimulating Factor × Clear all
NCT03823950 2020-03-13

Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients

University of Mississippi Medical Center

Phase 4 Unknown
150 enrolled
Classical hematology

Neoplasms, Chemotherapy-Induced Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡